Cargando…
A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388009/ https://www.ncbi.nlm.nih.gov/pubmed/35984119 http://dx.doi.org/10.1097/MD.0000000000030079 |
_version_ | 1784770128260366336 |
---|---|
author | Li, Xiao-Ling Gao, Rui-Xue Zhang, Qinhong Li, Ang Cai, Li-Na Zhao, Wei-Wei Gao, Sheng-Lan Wang, Yang Yue, Jinhuan |
author_facet | Li, Xiao-Ling Gao, Rui-Xue Zhang, Qinhong Li, Ang Cai, Li-Na Zhao, Wei-Wei Gao, Sheng-Lan Wang, Yang Yue, Jinhuan |
author_sort | Li, Xiao-Ling |
collection | PubMed |
description | BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to 2022 was analyzed using the Web of Science core collection database. We utilized CiteSpace software (6.1R2) for bibliometric analyses of countries/institutions/authors, keywords, keyword bursts, references, and their clusters. RESULTS: A total of 339 studies were identified with a continually increasing annual trend. The most productive country and collaboration was the United States. The top research hotspot is PD cognitive disorder. NMBM and artificial intelligence medical imaging have been applied in the clinical diagnosis, differential diagnosis, treatment, and prognosis of PD. The trends in this field include research on T1 weighted structure magnetic resonance imaging in accordance with voxel-based morphometry, PD cognitive disorder, and neuroimaging features of Lewy body dementia and Alzheimer disease. CONCLUSION: The development of NMBM in PD will be effectively promoted by drawing on international research hotspots and cutting-edge technologies, emphasizing international collaboration and institutional cooperation at the national level, and strengthening interdisciplinary research. |
format | Online Article Text |
id | pubmed-9388009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93880092022-08-23 A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science Li, Xiao-Ling Gao, Rui-Xue Zhang, Qinhong Li, Ang Cai, Li-Na Zhao, Wei-Wei Gao, Sheng-Lan Wang, Yang Yue, Jinhuan Medicine (Baltimore) Research Article BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to 2022 was analyzed using the Web of Science core collection database. We utilized CiteSpace software (6.1R2) for bibliometric analyses of countries/institutions/authors, keywords, keyword bursts, references, and their clusters. RESULTS: A total of 339 studies were identified with a continually increasing annual trend. The most productive country and collaboration was the United States. The top research hotspot is PD cognitive disorder. NMBM and artificial intelligence medical imaging have been applied in the clinical diagnosis, differential diagnosis, treatment, and prognosis of PD. The trends in this field include research on T1 weighted structure magnetic resonance imaging in accordance with voxel-based morphometry, PD cognitive disorder, and neuroimaging features of Lewy body dementia and Alzheimer disease. CONCLUSION: The development of NMBM in PD will be effectively promoted by drawing on international research hotspots and cutting-edge technologies, emphasizing international collaboration and institutional cooperation at the national level, and strengthening interdisciplinary research. Lippincott Williams & Wilkins 2022-08-19 /pmc/articles/PMC9388009/ /pubmed/35984119 http://dx.doi.org/10.1097/MD.0000000000030079 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Li, Xiao-Ling Gao, Rui-Xue Zhang, Qinhong Li, Ang Cai, Li-Na Zhao, Wei-Wei Gao, Sheng-Lan Wang, Yang Yue, Jinhuan A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title | A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title_full | A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title_fullStr | A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title_full_unstemmed | A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title_short | A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science |
title_sort | bibliometric analysis of neuroimaging biomarkers in parkinson disease based on web of science |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388009/ https://www.ncbi.nlm.nih.gov/pubmed/35984119 http://dx.doi.org/10.1097/MD.0000000000030079 |
work_keys_str_mv | AT lixiaoling abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT gaoruixue abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT zhangqinhong abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT liang abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT cailina abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT zhaoweiwei abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT gaoshenglan abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT wangyang abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT yuejinhuan abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT lixiaoling bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT gaoruixue bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT zhangqinhong bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT liang bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT cailina bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT zhaoweiwei bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT gaoshenglan bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT wangyang bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience AT yuejinhuan bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience |